SAMA and SABA + SAMA use associated with increased risk for heart failure, arrhythmia, and mortality versus no use ...
Labeling update reduces required post-infusion monitoring time for initial doses from 22 to 24 hours to 6 to 8 hours in patients with extensive-stage small cell lung cancer.
Progressive decrease in adjusted odds of hospitalization seen in association with vaccination versus no vaccination.
The NDA is supported by phase 3 LATITUDE data demonstrating rapid and durable skin clearance in adults with moderate to severe plaque psoriasis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results